Cost-utility analysis of multiple sclerosis rehabilitation in Iran-Reference-Cited by-同舟云学术

Cost-utility analysis of multiple sclerosis rehabilitation in Iran

Published:2023-08-28 Issue:10 Volume:23 Page:1129-1137
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Daroudi Rajabali¹²,Mousavi Mirtaher³,Shirazikhah Marzieh⁴,Alizadeh Zarei Mehdi⁵,Hendi Hamidreza⁶,Joghataei Faezeh⁶,Darvishi Ali⁷

Affiliation:

1. National Center for Health Insurance Research, Tehran, Iran

2. Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

3. Social Welfare Management Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

4. Social Determinants of Health Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

5. Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran

6. Department of social welfare management, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

7. Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iranan

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2023.2251689

Reference32 articles.

1. The genetics of multiple sclerosis: an up-to-date review

2. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition

3. Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis

4. Genetic epidemiology of multiple sclerosis.

5. The epidemiology of multiple sclerosis in Europe